1. Introduction {#sec1}
===============

Cancer remains a dark spot on the outer look of human being in this present century \[[@bib1]\]. It still maintains its position as the second cause of death in the entire world \[[@bib2], [@bib3]\]. Reichert and Wenger reported cancer to be a chromosomal syndrome which moves through the creation of carcinogenesis with several steps \[[@bib4]\]. This malignant neoplasia mostly starts as a restrained illness. However, it spreads all over the human body with time \[[@bib5]\]. More so, elongated cough, weight loss, unusual bleeding and swellings are possible signs of cancer in the body \[[@bib6], [@bib7]\].

Moreover, gastric cancer is a usual menace that occurs in the digestive system of a human being \[[@bib8]\]. It has been rated to be the fifth cause of death in the entire world and the third in cancer-related death \[[@bib9], [@bib10]\]. It mostly occurs in places like South America, eastern Asia, as well as Eastern Europe. Gastric cancer affects male much more than female and over 900000 new issues are reported every year \[[@bib11], [@bib12]\]. Several measures have been attempted over the years to combat gastric cancer in the human race like combination of chemotherapy, surgical resection, and radiation protocols; none of the curative means has been established \[[@bib13]\].

The role played by heterocycle in the discovery and development of novel drugs is imperative. 1, 2, 3-triazolo\[4, 5-d\]pyrimidine derivatives as heterocyclic molecules comprise of two active compounds (triazole and pyrimidine moieties). These are good class of compounds with renown biological activities which has drawn the attention of medicinal community in their exploration as anti-inflammatory \[[@bib14], [@bib15]\], anticancer \[[@bib16]\], antimicrobial \[[@bib17], [@bib18]\], diuretics \[[@bib19]\], analgesics \[[@bib20], [@bib21]\], antioxidant \[[@bib22]\].

Growing interest of researchers to develop a prediction method for biological activities before synthesis in recent times is becoming alarming. Therefore, quantitative structure--activity relationship (QSAR) helps in searching information connecting chemical structure/molecular properties to biological and other activities by developing a QSAR model. This approach can be used to predict the activities of newly designed compounds before synthesis. The scope of designing drugs and examining the process of drug activities have been widened through recent developments in QSAR studies \[[@bib23]\]. Several methods (heuristic method (HM), partial least squares (PLS), multiple linear regression (MLR), genetic algorithm (GA) and various types of artificial neural networks (ANN)) can be used for developing QSAR model which has brought advancement in QSAR studies \[[@bib24]\].

Therefore, thirty-two compounds as shown in [Figure 1](#fig1){ref-type="fig"} were optimized using density functional theory in order to obtain molecular parameters. Twenty-two compounds (**A1-A22**) from the entire compounds used in this work were taken form Li *et al.*, (2016) \[[@bib25]\], five compounds (**A23-A28**) were also taken from Li *et al.*, (2017) and the last set of compounds were taken from the work of Geng *et al.*, 2018. The anticancer activities of all these compounds had been experimentally reported \[[@bib26], [@bib27]\]; however, correlation between the molecular properties and anti-gastric cancer activity of 1,2,3-triazolo\[4,5-d\]pyrimidine hybrids have not been established. Also, the binding affinities of these compounds through molecular docking with gastric cancer cell line which can help in understanding pharmacokinetics and pharmacodynamics of drugs is yet to be established. This is also become imperative to understand the binding mode and non-bonding interactions between the compound\'s and the amino acid residues involved in the interaction. Therefore, the main objective of this work is to develop QSAR models through multiple linear regression, MLR (via ordinary least squares (OLS) and partial least squares (PLS)) and artificial neural network (ANN) form the calculated molecular descriptors of 1,2,3-triazolo\[4,5-d\]pyrimidine Hybrids. Also, to probe into non-bonding interactions in terms of affinity, hydrophilic interactions and hydrophobic interactions between these compounds and the gastric cancer cells line (**PDB ID:** [4oum](pdb:4oum){#intref0015}) downloaded from protein data bank \[[@bib28]\] via molecular docking.Figure 1The schematic structures of 1,2,3-triazolo\[4, 5-d\]pyrimidine analogues.Figure 1

2. Methodology {#sec2}
==============

Due to the flexibility of the rotatable bonds in these compounds, conformational search was performed on these compounds using semi-empirical AM1 method Monte Carlo search algorithm to select best conformer suitable for optimization. Five hundred (500) conformers were examined for each conformational search and the lowest-energy conformer of this conformational search was taken for further DFT calculations. Density functional theory method of B3LYP with 6-31+G∗ as basis set was used for optimization of 1, 2, 3-triazolo\[4, 5-d\]pyrimidine derivatives in gas phase and the energy calculation in water using Spartan 14 \[[@bib29]\]. The obtained molecular descriptors such as the highest occupied molecular orbital energy (E~HOMO~), the lowest unoccupied molecular orbital energy (E~LUMO~), band gap (eV), chemical hardness (η), global nucleophilicity, dipole moment (Debye), chemical potential (μ), log P, molecular weight (amu) and Ovality were extracted and used to develop Quantitative structural activities relationship (QSAR) models ([Table 1](#tbl1){ref-type="table"}). This was accomplished via SPSS/Gretl for multiple linear regression (Ordinary least square), XLSTAT \[[@bib30]\] for partial least square and MATLAB for the artificial neural network (ANN). The multiple linear regression reveals the correlation between the dependent variable and some independent variables. It is also used to select the parameters that are used for partial least square and artificial neural network. The developed QSAR models were validated by using statistical analysis such as correlation coefficient (R), adjusted correlation coefficient $R_{adj}^{2},$ cross-validation (CVR^2^) (Eqs. [(1)](#fd1){ref-type="disp-formula"} and [(2)](#fd2){ref-type="disp-formula"}) and the significance level (p-value) \[[@bib31]\] and the calculated variation inflation factors (VIF) which helps in detecting Multi-collinearity in QSAR analysis ([Eq. (3)](#fd3){ref-type="disp-formula"}) \[[@bib32]\]. Furthermore, docking study was carried out to predict the binding affinity and calculate equilibrium constant (Ki) using [Eq. (4)](#fd4){ref-type="disp-formula"}, and also to observe other non-bonded interactions between the studied ligands/compounds and the gastric cancer cells line (**PDB ID:** [4oum](pdb:4oum){#intref0020}).$$CV.R^{2} = 1 - \frac{\sum\left( {\text{Y}_{obs} - \text{Y}_{cal}} \right)^{2}}{{\sum\left( {\text{Y}_{obs} - {\overline{\mathrm{\Upsilon}}}_{obs}} \right)}^{2}}$$Table 1Pearson\'s correlation matrix for calculated parameters.Table 1MGC803E~HOMO~E~LUMO~PSAHBACON/nN4N5NORNOHVIFMGC8031.000-HOMO0.2961.0001.548LUMO0.4300.2231.0003.462PSA-0.139-0.0360.3361.0002.281HBA0.1670.2530.2260.5431.0008.506CON/n-0.240-0.162-0.1360.039-0.3321.0003.182N4-0.083-0.131-0.0960.093-04010.2031.0001.641N50.252-0.1010.4940.080-0.2990.6080.0081.0004.980NOR0.0880.0220.1900.4950.867-0.170-0.364-0.1551.0005.372NOH-0.4140.180-0.1160.0660.0350.020-0.006-0.025-0.0701.0001.139

The adjusted R^2^ could be calculated using [Eq. (2)](#fd2){ref-type="disp-formula"}$$R_{a}^{2} = \ \frac{\left( {N - I} \right) \times R^{2} - P}{N - 1 - P}$$$$VIF = \ \frac{1}{1 - R^{2}}$$$$\Delta G{^\circ} = - RTln\ K_{i}$$

3. Results and discussion {#sec3}
=========================

The optimization of 1,2,3-triazolo\[4,5-d\]pyrimidine Hybrids brought about several descriptors that describe anti-gastric cancer activities, but few were selected through Pearson correlation which was used to correlate the individual descriptor to the inhibition concentration (IC~50~). The selected descriptors were E~HOMO~, the E~LUMO~, polar surface area (PSA), Log P, Ovality and heteroatoms as displayed in [Table 2](#tbl2){ref-type="table"}. As shown in [Table 1](#tbl1){ref-type="table"}, there was a fair correlation between the calculated descriptors; hydrogen bond acceptor (HBA) is correlated with polar surface area by 0.543; electronic charge on nitrogen atom (5) is correlated with average of charge on all nitrogen atoms in 1,2,3-triazolo\[4,5-d\]pyrimidine derivatives by 0.608. Also, number of rings in the studied compounds is correlated with HBA by 0.867. Thus, Pearson correlation played a decisive role in the selection of descriptors that can describe the bioactivity of compounds.Table 2Calculate descriptors from 1,2,3-triazolo\[4,5-d\]pyrimidine derivatives.Table 2HOMOLUMOPSAHBACON/nN4N5NORNOHMGC-803A1-6.68-2.7453.1227-0.1890.0110.289410.91A2-6.44-2.5581.43310-0.165-0.0780.2611149.41A3-5.88-2.41107.57710-0.2110.070.23811410.05A4-5.66-2.4760.7968-0.178-0.0540.2649413.14A5-5.92-2.4769.2088-0.2520.1260.175957.41A6-6.13-2.6772.4578-0.2190.1190.228953.71A7-6.44-2.3976.7778-0.2090.0980.263942.31A8-6.36-2.4278.8878-0.230.0960.2399416.72A9-6.54-2.4959.0867-0.2270.1040.237946.02A10-6.62-2.673.5498-0.2430.0690.2391046.50A11-6.45-2.4176.7778-0.221-0.0040.2781047.10A12-6.47-2.4376.7778-0.2220.0050.28610411.28A13-6.42-2.3776.7778-0.2220.0720.27710410.98A14-6.57-2.5981.0729-0.2440.0720.1721044.76A15-6.63-2.5973.6349-0.2380.0410.20910416.38A16-6.42-2.3696.6679-0.2150.1330.2651047.68A17-6.49-2.6581.43310-0.169-0.0070.2411344.67A18-6.13-2.7172.4578-0.2180.1210.2099510.51A19-5.67-2.5560.7968-0.1780.0280.25947.62A20-6.65-2.6373.3988-0.24-0.0080.239943.82A21-6.45-2.5781.43310-0.164-0.0790.2531151.32A22-6.44-2.3876.7728-0.215-0.0460.264950.85A23-5.99-2.3166.5189-0.23-0.020.40810431.20A24-6.19-2.2975.70110-0.2920.1560.10211411.55A25-6.19-2.3373.25810-0.31-0.1370.12911416.37A26-6.05-2.2867.9719-0.27-0.0840.26710417.42A27-6.17-2.2174.3110-0.285-0.1180.23511419.22A28-5.82-2.2586.39311-0.317-0.1360.161259.21A29-6.22-2.8266.819-0.2850.0490.01910410.42A30-6.21-2.6570.9559-0.2540.10.08810316.65A31-6.24-2.8966.3869-0.293-0.2520.0531042.37A32-6.23-3.0267.8939-0.2560.0870.0611052.88

Moreover, the calculated variation inflation factors (VIF) which help in detecting multi-collinearity in QSAR analysis were all less than 5 in this work, which show that the selected descriptors were not collinearized.

3.1. QSAR study using multiple linear regression (MLR) {#sec3.1}
------------------------------------------------------

The QSAR model obtained using multiple linear regression via ordinary least square (OLS) was shown in [Eq. (5)](#fd5){ref-type="disp-formula"}. Several descriptors were chosen to show the relationship between the observed IC~50~ (MGC-803; **PDB ID** [4oun](pdb:4oun){#intref0025}) and the selected independent variables i.e., Hydrogen Bond Acceptor (HBA), NOH (Number of Heteroatom), N5, N4, Polar Surface Area (PSA), NOR (Number of Rings), CON/n ([Table 2](#tbl2){ref-type="table"}). The obtained equation using MLR is:$$\text{IC}_{50} = - 8.24612 + 7.09745\left( {HBA} \right) - 5.62245\left( {ΝΟΗ} \right) + 67.3318\left( {N5} \right) + 22.8898\left( {N4} \right) - 0.352905\left( {PSA} \right) - 2.79441\left( {NOR} \right) - 80.0762\left( \frac{CON}{n} \right)$$

N = 32, F = 8.02, P \< 0.0001, R^2^ = 0.700, $\mathbf{R}_{\mathbf{adj}}^{2}$ = 0.613, C.VR^2^ = 0.902, MSE = 1.205.

The developed model revealed that HBA, N5, and N4 contributed positively to the studied bioactivity while NOH, PSA, NOR and CON/n contributed negatively. As reported by Taourati *et al.*, (2017), the reliability of the developed QSAR model is a function of greater correlation coefficient (R^2^), i.e., ≥0.5 \[[@bib33]\]. The value obtained for R^2^, adjusted R^2^ and calculated cross-validation, C.VR^2^, showed that the developed model using MLR has a good predictability, and it is statistically acceptable, since the value for adjusted R^2^ ≥ 0.6 which is the standard and C.VR^2^ is greater than the standard (0.5) \[[@bib34]\]. The R^2^ showed that the fitness of the predicted bioactivity to the observed bioactivity is reasonable and it is dependable ([Figure 2](#fig2){ref-type="fig"}).Figure 2The calculated predicted IC~50~ against the observed IC~50~ using MLR via OLS.Figure 2

3.2. QSAR study using partial least square (PLS) {#sec3.2}
------------------------------------------------

Quantitative evaluation of derivatives attached to 1, 2, 3-triazolo\[4,5-d\]pyrimidine by enhancing structural-activity-relationship were also observed using partial least square. The calculated descriptors which described the anti-gastric cancer activity of 1, 2, 3-triazolo\[4,5-d\]pyrimidine and its derivatives using MLR were subjected to PLS analysis. Thirty-two molecular compounds were used as a training set, and correlation coefficient (R^2^), adjusted R^2^ and calculated cross-validation (C.VR^2^) were used for evaluation, and validation of the developed model ([Eq. (6)](#fd6){ref-type="disp-formula"}). The role played by the selected descriptors in the developed model are highly imperative and these were graphically displayed in [Figure 3](#fig3){ref-type="fig"}.$$\text{IC}_{50} = - 8.241 - 0.352 \ast PSA + 7.097 \ast HBA - 80.050 \ast \frac{CON}{n} + 22.887 \ast N4 + 67.324 \ast N5 - 2.795 \ast NOR - 5.623 \ast NOH$$Figure 3Graphical representation of the coefficient against the independent variables.Figure 3

N = 32, R^2^ = 0.701, $\mathbf{R}_{\mathbf{adj}}^{2}$ = 0.613, C.VR^2^ = 0.902, F = 8.028, P \< 0.0001, MSE = 16.078.

The observed statistical values for PLS showed that the developed model is dependable and predictive as shown in [Table 3](#tbl3){ref-type="table"}. Also, the indiscriminate spread of the residuals on the two sides of zero as shown in [Figure 4](#fig4){ref-type="fig"} revealed that the developed model did not display any relative inaccuracy. The calculated R^2^ for PLS revealed that the predicted IC~50~ fitted well with observed IC~50~ which shows the dependability of the developed model ([Figure 5](#fig5){ref-type="fig"}).Table 3Stepwise regression result for anti-gastric cancer activity.Table 3Obs. IC~50~OLS-MLRResidualPLS-MLRResidualANN-MLRResidualA110.919.291.629.2871.62310.8850.02A29.419.76-0.359.766-0.3569.3820.02A310.056.073.986.0643.98610.0460.00A413.1410.232.9110.2322.90813.1120.02A57.415.691.725.6931.7177.3910.01A63.715.31-1.65.313-1.6033.7070.00A72.3110.49-8.1810.488-8.1782.3010.00A816.729.766.969.7636.95716.7030.01A96.029.46-3.449.459-3.4395.9910.02A106.59.27-2.779.274-2.7746.4710.02A117.17.33-0.237.329-0.2297.0950.00A1211.288.153.138.1533.12711.250.02A1310.989.081.99.0811.89910.950.02A144.769.35-4.599.355-4.5954.740.01A1516.3813.283.113.2813.09916.350.02A167.689.19-1.519.190-1.5107.670.00A174.674.77-0.14.774-0.1044.650.01A1810.514.006.514.0006.51010.480.02A197.6211.17-3.5511.166-3.5467.590.02A203.8210.12-6.310.119-6.2993.790.02A211.323.5-2.183.501-2.1811.30.01A220.852.12-1.272.118-1.2680.840.00A2331.227.154.0527.1524.04831.170.02A2411.5516.61-5.0616.605-5.05511.520.02A2516.3714.022.3514.0202.35016.340.02A2617.4218.89-1.4718.884-1.46417.390.02A2719.2219.220.0019.2190.00119.190.02A289.2110.74-1.5310.736-1.5269.190.01A2910.426.843.586.8423.57810.40.01A3016.6514.332.3214.3342.31616.640.00A312.373.03-0.663.032-0.6622.340.02C322.882.210.672.2130.6672.870.00Figure 4The residuals against observed IC~50~.Figure 4Figure 5The calculated predicted IC~50~ against the observed IC~50~ using multiple non-linear regression method.Figure 5

3.3. Artificial neural network (ANN) {#sec3.3}
------------------------------------

Artificial neural network via back propagation neural network (BPNN) has been a veritable tool in developing a predictive and efficient QSAR model \[[@bib35]\]. It was used to establish the structural activity relationship between the selected descriptors from MLR and the experimental IC~50~.

The obtained R^2^ (0.999) and MSE (0.24) for BPNN show its effectiveness in prediction than MLR and PLS ([Table 2](#tbl2){ref-type="table"}). According to Taourati et al., 2017 \[[@bib33]\], reliable and predictive QSAR model is a function of higher correlation coefficient (R^2^) and lower mean squared errors; thus, back propagation neural network has proved to be a veritable tool in developing QSAR model with efficient predictability [(Figure 6)](#fig6){ref-type="fig"}.Figure 6Graphical illustration of predicted and observed bioactivity using artificial neural network method.Figure 6

3.4. Molecular docking study {#sec3.4}
----------------------------

A way of recognising pharmacophore with the capacity to interconnect with an enzyme which is a function of binding affinity defines docking study. According to Ritchie *et al.*, 2008, the impulsiveness of the binding relationship between ligand and the studied enzyme could be improved by lowering of binding energy \[[@bib36]\]. Therefore, the summary of the docking results showing in [Table 3](#tbl3){ref-type="table"}, indicated that the affinity calculated for **A22** was -8.40 kcal/mol. This was in line with observed inhibitory activity of **A22** against gastric cancer cell line as a compound with highest inhibition. This can be due to the benzyl groups at R^1^ and R^2^ positions in **A22** which give rise to amide-π stacking in addition to other interactions in the active gorge of the receptor. The relationship between the cytotoxicity and affinity was displayed in [Figure 7](#fig7){ref-type="fig"}. For concise understanding of the docked results, five ligand-receptor complexes were selected and analysed vis-à-vis **A17, A18, A20, A21 and A22** docked with receptor. The amino acid residues involved in hydrophobic interactions (HIs) with **A17, A18, A20, A21** and **A22** with **4oum** are ARG-1004, VAL-1018, LEU-1034 and PRO-1016 for **A17**; PRO-1010, PRO-1016, LEU-1034, VAL-1018, ARG-1004 for **A18**; ASP-1020, ARG-1004, LEU-1008, PRO-1010, VAL-1018, LEU-1032 for **A20**; VAL-1018, ARG-1004, ASP-1020, LEU-1032, GLN-1033 for **A21**, and VAL-1018, ARG-1004, ASP-1020, LEU-1032 and GLN-1033 for **A22** ([Figure 8](#fig8){ref-type="fig"}). Comparing these compounds with the standard drug, 5-Fu, it was observed that all the studied compounds in this work inhibited more effectively and also have lower affinity (\<-4.30 kcal/mol and K~i~ \> 1.42 × 10^3^) than the standard compound used (5-FU) as shown in [Table 4](#tbl4){ref-type="table"}. Therefore, the combination of both triazole and pyridine moieties would prove to be a very good architecture in designing potent drugs that will be effective inhibit gastric cancer than 5-FU. The residues involve in the interactions between 5-FU and 4oum are PHE-1019, ARG-1004, and VAL-1018 and the inhibition constant (K~i~) was very low compared to the values obtained for other studied compounds, a function of the calculated binding affinity.Figure 7Correlation between Binding affinity and Observed IC~50~.Figure 7Figure 8Molecular binding interaction between A17, A18, A20, A21, and A32 with 4oum.Figure 8Table 4Interactions between ligands and 4oum receptor.Table 4CompScoringKHydrogen BondsAmino Acid ResiduesA1-7.21.90913 × 10^5^-A2-7.32.26037 × 10^5^(i) ARG-1004, LIG: O (ii) ARG-1004, LIG: OVAL-1018, PRO-1016, LEU-1034, GLY-1011, PRO-1010A3-7.01.36190 × 10^5^(i) ARG-1004, LIG:N (ii) i) ARG-1004, LIG:NASP-1020, LUE-1008 PRO-1010, VAL-1018A4-7.11.61246 × 10^5^(i) ARG-1004, LIG:N (ii) ARG-1004, LIG:NVAL-1018, LUE-1008, PRO-1010A5-7.11.61246 × 10^5^(i) PRO-1004, LIG:H (ii) ARG-1004, LIG:NVAL-1081, PRO-1016, ARG-1004A6-7.32.26037 × 10^5^-PRO-1016, VAL-1018, LEU-1034, GLY-1011, PRO-1010A7-7.53.16862 × 10^5^ARG-1004, LIG:NASP-1020, ARG-1004, LEU-1008, PRO-1010, VAL-1018, LEU-1032A8-7.11.61246 × 10^5^(i) ARG-1004, LIG:N (ii) ARG-1004, LIG:N (iii) GLN-1033LEU-1032, GLN-1032, VAL-1018, PRO-1010, LEU-1008, ARG-1004A9-7.32.26037 × 10^5^(i) ARG-1004, LIG: N (ii) ARG-1004, LIG: N (iii) ARG-1004, LIG: NARG-1004, PRO-1016, ASP-1020A10-7.74.44181 × 10^5^ARG-1004, LIG: NVAL-1018, PRO-1010, LEU-1008, ARG-1004A11-7.32.26037 × 10^5^ASP-1020, LIG:O (ii) ARG-1004, LIG:OASP-1020, ARG-1004A12-7.42.67624 × 10^5^SER-1006, LIG:N (ii) ARG-1004, LIG:NSER-1006, ARG-1004A13-7.32.26037 × 10^5^-PRO-1010, PRO-1016, VAL-1018,A14-6.89.715 × 10^4^(i)ASP-1020, LIG:H (ii) ARG-1004, LIG-OASP-1020, ARG-1004, VAL-1018, LEU-1008, PRO-1010A15-6.89.715 × 10^4^(i) SER-1006, LIG:N (ii) ARG-1004, LIG:N (iii) ARG-1004, LIG:NSER-1006, ARG-1004,ASP-1020, VAL-1018, LEU-1008, PRO-1010A16-7.32.26037 × 10^5^(i) ARG-1004, LIG:N (ii) ARG-1004, LIG:NARG-1004, VAL-1018, LEU-1032A17-7.85.25902 × 10^5^(i) ARG-1004, LIG:O (ii) ARG-1004, LIG:OARG-1004, VAL-1018, LEU-1034, PRO-1016A18-8.21.033440 × 10^6^-PRO-1010, PRO-1016, LEU-1034, VAL-1018, ARG-1004A19-7.53.16862 × 10^5^(i) ARG-1004, LIG:N (ii) ARG-1004, LIG:NARG-1004, VAL-1018, ASP-1020, LEU-1032A20-7.85.25902 × 10^5^ARG-1004, LIG:NASP-1020, ARG-1004, LEU-1008, PRO-1010, VAL-1018, LEU-1032A21-8.07.37217 × 10^5^(i) ARG-1004, LIG:N (ii) ARG-1004, LIG:NVAL-1018, ARG-1004, ASP-1020, LEU-1032, GLN-1033A22-8.41.448689 × 10^6^(i) SER-1006, LIG:N (ii) ARG-1004, LIG: NSER-1006, ARG-1004, PRO-1010, LEU-1008, VAL-1018, GLN-1033, LEU-1032A23-6.12.9788 × 10^4^(i) PHE-1019, LIG:S (ii) ARG-1004, LIG:H (iii) ARG-1004, LIG:NPHE-1019, ARG-1004,A24-6.91.15027 × 10^5^A25-6.66.9305 × 10^4^(i) ARG-1004, LIG: NARG-1004, LEU-1008, PRO-1010 and VAL-1018A26-6.66.9305 × 10^4^(i) ASN-1007, LIG:H (ii) SER-1006, LIG:NPRO-1010, LEU-1008, ASN-1007, VAL-1018, SER-1006 and ARG-1004A27-6.44.9439 × 10^4^(i) ARG-1004, LIG: NVAL-1018, LEU-1032, ARG-1004, PRO-1010 and LEU-1008A28-6.91.15027 × 10^5^(i) ARG-1004, LIG: NARG-1004, VAL-1018, PRO-1016, ASN-1007 and LEU-1032A29-7.32.26037 × 10^5^(i) ARG-1004, LIG: N (ii) ARG-1004, LIG: NLEU-1008, PRO-1010, ARG-1004, VAL-1018, and LEU-1032A30-6.66.9305 × 10^4^(i) ARG-1004, LIG: N (ii) ARG-1004, LIG: NLEU-1008, PRO-1010, VAL-1018, LEU-1032 and ARG-1004A31-7.63.75159 × 10^5^(i) ARG-1004, LIG: N (ii) ARG-1004, LIG: NLEU-1008, PRO-1010, VAL-1018, LEU-1032 and ARG-1004A32-7.74.44181 × 10^5^(i) ARG-1004, LIG: N (ii) ARG-1004, LIG: NPRO-1010, LEU-1008, VAL-1018, ARG-1004 and LEU-1032

4. Conclusion {#sec4}
=============

Bioactivity of 32 sets of 1, 2, 3-triazolo\[4, 5-d\]pyrimidine derivatives was studied by observing the calculated electronic descriptors using density functional theory method via 6-31+G(d,p) as a basis set. The selected molecular descriptors after optimization of these of 1, 2, 3-triazolo\[4, 5-d\]pyrimidine analogues were used to develop QSAR models for anti-gastric cancer activity. The methods used (MLR, PLS, and ANN) were predictive. However, ANN prediction is more effective than other methods used in this study. Also, the molecular docking study was conducted to reveal the binding interactions between the studied compounds and the receptor. The results showed that 2-(1-(2-(3-benzyl-5-(benzylthio)-3H-\[1,2,3\]triazolo\[4,5-d\]pyrimidin-7-yl)hydrazono)ethyl)phenol (**A22)** presented lowest affinity and highest inhibitory activity than other compounds; thus most promising drug-like compound for gastric cancer inhibition.
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